General Information of the Compound
Compound ID
CP0510317
Compound Name
(2-(1H-indol-3-yl)ethylamino)(pyrimidin-2-ylamino)methaniminium
    Show/Hide
Structure
Formula
C15H16N6
Molecular Weight
280.335
Canonical SMILES
NC(Nc1ncccn1)=NCCc1c[nH]c2ccccc12
    Show/Hide
InChI
InChI=1S/C15H16N6/c16-14(21-15-18-7-3-8-19-15)17-9-6-11-10-20-13-5-2-1-4-12(11)13/h1-5,7-8,10,20H,6,9H2,(H3,16,17,18,19,21)
    Show/Hide
InChIKey
RWEYERKZCOOCCP-UHFFFAOYSA-N
Physicochemical Property
logP
1.9272
Rotatable Bonds
4
Heavy Atom Count
21
Polar Areas
91.98
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
3
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 17036152
ChEMBL ID
CHEMBL1098444
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00862, Adenosine receptor A2a
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 5900 nM
   TI
   LI
   LO
   TS